RPS6KA3 Gene Mental Retardation X-Linked Type 19 Genetic Test sale cost 4400 AED
UBE2A Gene Mental Retardation X-Linked Syndromic Nascimento-Type Genetic Test sale cost 4400 AED UBE2A Gene Mental Retardation X-Linked Syndromic Nascimento-Type Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
EFHC2 Gene Mental Retardation X-Linked EFHC2 Related Genetic Test sale cost 4400 AED EFHC2 Gene Mental Retardation X-Linked EFHC2 Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

RPS6KA3 Gene Mental Retardation X-Linked Type 19 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RPS6KA3 gene, located on the X chromosome, plays a crucial role in cognitive development and function. Mutations in this gene are associated with Coffin-Lowry syndrome, a condition characterized by intellectual disability, distinctive facial features, and skeletal abnormalities. This condition predominantly affects males, but females can be carriers and may exhibit milder symptoms. The “RPS6KA3 Gene Mental Retardation X-Linked Type 19 Genetic Test” is a specialized diagnostic tool aimed at detecting mutations within the RPS6KA3 gene to confirm a diagnosis of Coffin-Lowry syndrome or to identify carriers within a family. Conducted at DNA Labs UAE, a leading facility in genetic testing, this test provides families and individuals with critical information for managing the condition, understanding the risk of transmission to offspring, and accessing appropriate support and interventions. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the RPS6KA3 gene.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RPS6KA3 Gene Mental Retardation X-linked Type 19 Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for RPS6KA3 Gene Mental Retardation, X-linked type 19 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RPS6KA3 Gene Mental Retardation, X-linked type 19.

Test Details

The RPS6KA3 gene is associated with a condition called mental retardation, X-linked type 19 (MRX19). This genetic test, known as NGS (Next-Generation Sequencing), is used to analyze the DNA sequence of the RPS6KA3 gene to detect any mutations or variations that may be responsible for MRX19.

Mental retardation, X-linked type 19 is a genetic disorder that primarily affects males. It is characterized by intellectual disability, delayed speech and language development, behavioral problems, and some physical abnormalities. The severity of symptoms can vary widely among affected individuals.

NGS is a high-throughput DNA sequencing method that allows for the analysis of multiple genes simultaneously. It can detect a wide range of genetic variations, including point mutations, insertions, deletions, and rearrangements. By sequencing the RPS6KA3 gene, this test can identify any genetic changes that may be causing MRX19.

The results of the NGS genetic test can help in confirming a diagnosis of MRX19 and provide valuable information for genetic counseling and family planning. It can also aid in the development of personalized treatment plans and management strategies for individuals with MRX19.

Test Name RPS6KA3 Gene Mental retardation X-linked type 19 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RPS6KA3 Gene Mental retardation, X-linked type 19 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RPS6KA3 Gene Mental retardation, X-linked type 19
Test Details

The RPS6KA3 gene is associated with a condition called mental retardation, X-linked type 19 (MRX19). This genetic test, known as NGS (Next-Generation Sequencing), is used to analyze the DNA sequence of the RPS6KA3 gene to detect any mutations or variations that may be responsible for MRX19.

Mental retardation, X-linked type 19 is a genetic disorder that primarily affects males. It is characterized by intellectual disability, delayed speech and language development, behavioral problems, and some physical abnormalities. The severity of symptoms can vary widely among affected individuals.

NGS is a high-throughput DNA sequencing method that allows for the analysis of multiple genes simultaneously. It can detect a wide range of genetic variations, including point mutations, insertions, deletions, and rearrangements. By sequencing the RPS6KA3 gene, this test can identify any genetic changes that may be causing MRX19.

The results of the NGS genetic test can help in confirming a diagnosis of MRX19 and provide valuable information for genetic counseling and family planning. It can also aid in the development of personalized treatment plans and management strategies for individuals with MRX19.

SKU: TEST-1632 Category:

Related products